The prognostic relevance of BRCA in breast cancer is also questionable: some studies demonstrated that patients with a BRCA1/2 mutation had worse OS [29,30,31,32], and other studies showed no significant differences when compared with non-carriers [33,34,35,36]. This evidence concerns the gene BRCA1 and breast cancer.